Developing a new medical product? All you need to know!

DCU medical

Give your product the best chance of success with Afortiori Development's innovative approach to navigating regulation, funding and clinical testing. Learn how to navigate the complex environment of regulation, funding and clinical testing with an introduction to Afortiori Development's innovative new approach to product development.  

One-to-one meetings

After this seminar, the Afortiori team are available for one-to-one 30 minute meetings. These meetings are strictly by appointment only and must be booked in advance with



Dr. Nicola Wall 

Nicola has over 20 years extensive experience within the pharmaceutical, medical technology and healthcare sectors in the UK, Ireland and the USA. She has led the delivery of multiple types of projects and clinical trials across a range of therapeutic areas. She has experience in all areas of clinical development including regulatory, data management, safety, quality and organisational effectiveness. In 2016 Nicola founded Afortiori Development and as Chief Executive Officer leads the organisation to address the need for improved clinical trial design, planning and management, designing a wide range of studies to meet both regulatory and commercial objectives by working closely with clients, in a partnership role, throughout the clinical development journey.

 Dr. Dan Lace

Dan has over 30 years of medical leadership experience as a healthcare executive across a wide range of pharmaceutical, device, diagnostic, managed care, and consulting businesses. He has served as Chief Medical Officer and has held senior leadership positions in global pharmaceutical and device companies, as well as in US managed care organisations. Dan’s experience spans multiple disease areas and he provides medical leadership and expertise in strategy development and implementation of innovative and creative solutions to healthcare issues. He provides expertise in analysis and strategic implementation of healthcare reform issues that impact health plans, providers, managed markets and industry. Dan is based in the Chicago office.

 Dr. Kieran Conole

Kieran has worked across roles in research and development and manufacturing within the Pharmaceutical and Medical device industries before transitioning to Regulatory Affairs. Kieran previously supported Class III Combination Devices and Class II devices for a multinational company in Ireland. Kieran is currently a Regulatory and Quality Compliance Consultant at Med-Di-Dia where he supports clients with all device classes transitioning to the new EU Medical Device Regulation with expertise in Technical Documentation, Regulatory Strategy and Risk Management.



Do you have questions about Developing a new medical product? All you need to know! Date: 17th October 2019? Contact the organiser